Vibrant colours including red, orange, and blue are in demand as food and beverage brands tap into colour psychology to ...

Erythrosine, also called Red Dye No. 3 ... The Ghana Food and Drugs Authority (FDA) does not permit the substance to be used in the production of tomato paste. This is because it has been found ...

Red Dye 3, also known as erythrosine or E127 in Europe ... Animal studies have shown that Red Dye 3 can cause thyroid cancer in male rats. Although FDA argues that the relevance to humans is ...

According to an FDA report obtained by NBC News, 89 people across 15 states fell ill in an E. coli outbreak in November, but the agency closed its investigation in February without publicly ...

He spent much of the conversation with Kelly lambasting his agency for its ties to industry, and said he was shocked to learn that drug industry representatives are allowed to sit on FDA advisory ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and consider other paths to market, The Wall Street Journal reports. Women’s ...

“The claim that the FDA is suspending routine food safety inspections is false. FDA is actively working to ensure continuity of operations during the reorganization period and remains committed ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide ...

Two weeks later, about 15 of 20 workers in the FDA’s Division of Food Processing Science and Technology in Illinois were told their jobs were being eliminated, according to a person familiar ...

The FDA is unlikely to appeal the March 31 federal court order that set aside a final rule asserting the agency’s jurisdiction over LDTs, attorneys who handle regulatory matters said in interviews.

Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biological product intended to treat a rare disease or condition, which is generally a disease or condition that ...

Novo Nordisk, the Danish-headquartered manufacturer, informed the FDA on April 3 that counterfeit 1-milligram injections of semaglutide were being distributed outside its authorized supply chain.